AeRang Kim

发表

Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer

Danielle K. Manning, N. Lennon, E. V. Van Allen, 2022, Nature Medicine.

Rhabdomyosarcoma of the head and neck in children: review and update.

J. Murnick, B. Reilly, Sukgi S. Choi, 2015, International journal of pediatric otorhinolaryngology.

Foley Catheter as a Vaginal Stent in a Toddler with Vaginal Rhabdomyosarcoma.

V. Gomez-Lobo, P. Mohindra, AeRang Kim, 2017, Journal of pediatric and adolescent gynecology.

HISTOPATHOLOGIC EVALUATION OF ATYPICAL NEUROFIBROMATOUS TUMORS AND THEIR TRANSFORMATION INTO MALIGNANT PERIPHERAL NERVE SHEATH TUMOR IN NEUROFIBROMATOSIS 1 PATIENTS – A CONSENSUS OVERVIEW

Karlyne M. Reilly, C. Antonescu, A. Stemmer-Rachamimov, 2017 .

MEK Inhibitors for Neurofibromatosis Type 1 Manifestations: Clinical Evidence and Consensus.

M. Loh, Michael Fisher, K. Walsh, 2022, Neuro-oncology.

Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid Tumor

Danielle K. Manning, B. Crompton, N. Lindeman, 2021, JCO precision oncology.

Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer

A. Cherniack, N. Lindeman, G. Reaman, 2022, JCO precision oncology.

Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use

C. Bettegowda, D. Evans, C. Hanemann, 2021, Neurology.

Focused Ultrasound for Pediatric Diseases.

C. Hennekens, P. Ghanouni, J. Ragheb, 2022, Pediatrics.

Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1

E. Dombi, James E. Bost, P. Yarmolenko, 2021, Neuro-oncology advances.

TK216 for relapsed/refractory Ewing sarcoma: Interim phase 1/2 results.

P. Anderson, R. Riedel, J. Ludwig, 2021 .

Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma.

M. Ladanyi, B. Crompton, L. Macconaill, 2023, JCO precision oncology.

The need for new treatments targeting MPNST: the potential of strategies combining MEK inhibitors with antiangiogenic agents.

N. Ratner, H. Peinado, AeRang Kim, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Clinical impact of molecular tumor profiling in pediatric, adolescent, and young adult patients with extra-cranial solid malignancies: An interim report from the GAIN/iCat2 study.

W. London, L. Corson, A. Sabnis, 2021 .